article thumbnail

Data Lake Governance with Tagging in Databricks Unity Catalog

Perficient: Drug Development

Providing this level of access control substantially increases the quality of governance while reducing the workload involved. Tagging can make these assets more seachable, manageable and governable. Geo-coding data with tags to comply with European regulations is also a possible target of opportunity.

article thumbnail

UK regulator cuts late-stage clinical trial approval time to two weeks

Drug Discovery World

Dr June Raine, MHRA Chief Executive, said: “Clinical trials regulation should be flexible and risk-proportionate so that the regulatory requirements are geared to the risk that a trial presents. The post UK regulator cuts late-stage clinical trial approval time to two weeks appeared first on Drug Discovery World (DDW).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Explainer: What a government shutdown would mean for the FDA (Updated)

Agency IQ

In this piece, AgencyIQ explains what a government shutdown would mean for FDA’s regulatory processes and for the industry it regulates. BY LAURA DIANGELO, MPH With Congress again debating the passage of appropriations legislation, the FDA is facing a potential shutdown of operations as of Midnight on March 1.

article thumbnail

Federal Government to Regulate Staffing at Nursing Homes for First Time

Drugs.com

FRIDAY, Sept. 1, 2023 -- Nursing homes will soon have to meet federal minimum staffing requirements, the U.S. Department of Health and Human Services (HHS) announced Friday. Establishing minimum staffing standards for nursing homes will improve.

Nurses 85
article thumbnail

Outlining the Legal Arguments Against FDA’s Proposed Rule Regulating LDTs

FDA Law Blog: Biosimilars

Gonzalez — In a new publication in the Washington Legal Foundation’s (WLF) Legal Backgrounder , we argue that FDA’s recent proposed rule regulating Laboratory Developed Tests (LDTs) is vulnerable to legal challenge, once finalized. By Jeffrey N. Gibbs & Steven J.

article thumbnail

Article EMA Thank You British regulators tease new device regulations in informative live session

Agency IQ

British regulators tease new device regulations in informative live session This week, the British regulator MHRA offered a new peek into its planned medical device regulations. BY COREY JASEPH, MS, RAC | MAR 5, 2024 11:10 PM CST Quick background on medical device regulation in the U.K. post-market regulation here.]

article thumbnail

Foxp3 protein governs regulatory T cell genome structure

Drug Target Review

Regulating immunosuppression Beyond serving as a genetic on-off switch, Foxp3 controls greater genetic structural change within regulatory T cells, controlling chromatin architecture changes that subsequently guide the functional success of the peacekeeping immune cells.